NASDAQ:PALI

Palisade Bio Stock Insider Trading

Healthcare > Biotechnology

Buy PALI

*Your capital is at risk

$1.89

-0.0700 (-3.57%)

At Close: Jul 13, 2026

Palisade Bio Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 85.99. In total, the insiders bought 48.33M and sold 209.14K PALI shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	85.99
● Buy	48.33M shares
● Sell	209.14K shares
89% Buy Activity Negligible or No Correlation
Sell Signal Low Confidence Jul 07, 2026 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory positive Insider Power Score of 85.99. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Jul 09, 2026 Buy	Common Stock P-Purchase	Baltera Robert Jr. Director	Director	25 000 Value: $48.9K
Jul 08, 2026 Buy	Common Stock P-Purchase	Baltera Robert Jr. Director	Director	20 000 Value: $39.8K
Jul 07, 2026 Sell	Common Stock S-Sale	Jones Mitchell Lawrence Chief Medical Officer	Officer	51 880 Value: $106.5K
Jul 07, 2026 Buy	Common Stock P-Purchase	Baltera Robert Jr. Director	Director	30 000 Value: $61.0K
Jul 07, 2026 Buy	Common Stock M-Exempt	Finley John David CEO, CFO	CEO / President	133 Value: $93
Jul 07, 2026 Sell	Common Stock S-Sale	Finley John David CEO, CFO	CEO / President	146 798 Value: $303.3K
Jul 07, 2026 Buy	Series 2 Common Stock Purchase Warrant M-Exempt	Finley John David CEO, CFO	CEO / President	133 Value: $93
Jul 06, 2026 Buy	Restricted Stock Units M-Exempt	Jones Mitchell Lawrence Chief Medical Officer	Officer	131 167 Value: $267.6K
Jul 06, 2026 Buy	Common Stock P-Purchase	Baltera Robert Jr. Director	Director	20 000 Value: $41.0K
Jul 06, 2026 Buy	Common Stock M-Exempt	Jones Mitchell Lawrence Chief Medical Officer	Officer	131 167 Value: $267.6K
Jul 06, 2026 Buy	Restricted Stock Units M-Exempt	Finley John David CEO, CFO	CEO / President	335 167 Value: $683.7K
Jul 06, 2026 Buy	Common Stock M-Exempt	Finley John David CEO, CFO	CEO / President	335 167 Value: $683.7K
Jul 02, 2026 Buy	Common Stock P-Purchase	Baltera Robert Jr. Director	Director	10 000 Value: $19.8K
Jul 01, 2026 Buy	Common Stock P-Purchase	Baltera Robert Jr. Director	Director	20 000 Value: $39.6K
Jun 10, 2026 Buy	Common Stock A-Award	Baltera Robert Jr. Director	Director	336 904 Value: $566.0K
Jun 10, 2026 Buy	Common Stock J-Other	Baltera Robert Jr.	Director	0 Value: $0
Jun 10, 2026 Buy	Common Stock J-Other	Zwick Jordan Michael	Director	0 Value: $0
Jun 10, 2026 Buy	Common Stock A-Award	Zwick Jordan Michael Director	Director	336 904 Value: $566.0K
Jun 10, 2026 Buy	Restricted Stock Units M-Exempt	Chuang Emil Director	Director	20 200 Value: $33.9K
Jun 10, 2026 Buy	Common Stock A-Award	Chuang Emil Director	Director	592 300 Value: $995.1K
Jun 10, 2026 Buy	Common Stock M-Exempt	Chuang Emil Director	Director	20 200 Value: $33.9K
Jun 10, 2026 Buy	Restricted Stock Units M-Exempt	Williams Donald Allen Director	Director	60 666 Value: $101.9K
Jun 10, 2026 Buy	Common Stock A-Award	Williams Donald Allen Director	Director	1 498 900 Value: $2.52M
Jun 10, 2026 Buy	Common Stock M-Exempt	Williams Donald Allen Director	Director	60 666 Value: $101.9K
Jun 10, 2026 Buy	Restricted Stock Units M-Exempt	Wei Binxian Director	Director	20 200 Value: $33.9K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT PALISADE BIO, INC.

Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing oral therapies that target serious diseases associated with the breakdown of the mucosal barrier protecting the gastrointestinal tract. Its lead therapeutic candidate is LB1148, an oral liquid formulation of the digestive enzyme inhibitor that is intended to inhibit digestive enzyme activity and preserve gut integrity during int...

Read Full Profile Here